Speciality Medicines Limited (BOM:544738)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Wholesale - Drugs	752.85M	582.71M	275.25M	232.41M	404.44M
Wholesale - Drugs Growth	29.20%	111.71%	18.43%	-42.54%	-
Total	752.85M	582.71M	275.25M	232.41M	404.44M
Total Growth	29.20%	111.71%	18.43%	-42.54%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India	179.88M	116.98M	66.85M	362.36M
India Growth	53.78%	74.99%	-81.55%	-
Export	402.83M	158.27M	165.56M	42.08M
Export Growth	154.52%	-4.40%	293.48%	-
Total	582.71M	275.25M	232.41M	404.44M
Total Growth	111.71%	18.43%	-42.54%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 10, 2026

Data Sources Report a data error